دورية أكاديمية
Assessing the Suitability of CHA 2 DS 2 -VASc for Predicting Adverse Limb Events and Cardiovascular Outcomes in Peripheral Artery Disease Patients with Percutaneous Transluminal Angioplasty: A Retrospective Cohort Study.
العنوان: | Assessing the Suitability of CHA |
---|---|
المؤلفون: | Cheng YT; Cardiovascular Center, Taichung Veterans General Hospital, 1650 Section 4 Taiwan Boulevard, Xitun District, Taichung 40705, Taiwan., Chang FL; Department of Nursing, Taichung Veterans General Hospital, 1650 Section 4 Taiwan Boulevard, Xitun District, Taichung 40705, Taiwan., Li PH; Department of Food and Nutrition, Providence University, 200 Section 7, Taiwan Boulevard, Shalu District, Taichung City 43301, Taiwan., Lu WC; Department of Food and Beverage Management, Chung-Jen Junior College of Nursing, Health Sciences and Management, 217, Hung-Mao-Pi, Chiayi City 60077, Taiwan., Chiu CS; Department of Dermatology, Taichung Veterans General Hospital, 1650 Section 4 Taiwan Boulevard, Xitun District, Taichung 40705, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, 145 Xingda Road, South District, Taichung 402, Taiwan.; College of Biotechnology and Bioresources, Da-Yeh University, 168, University Road, Dacun, Changhua 51591, Taiwan. |
المصدر: | Biomedicines [Biomedicines] 2024 Jun 20; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 20. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI AG, [2013]- |
مستخلص: | Patients with peripheral artery disease (PAD) are at high risk of major adverse limb events (MALEs) and major adverse cardiovascular events (MACEs). CHA |
References: | Circ Res. 2021 Jun 11;128(12):1818-1832. (PMID: 34110907) Biomedicines. 2023 Jun 26;11(7):. (PMID: 37509465) J Thromb Haemost. 2022 May;20(5):1193-1205. (PMID: 35170216) Heart Rhythm. 2016 Jan;13(1):46-53. (PMID: 26277496) Angiology. 2020 Aug;71(7):658-665. (PMID: 32342699) J Am Coll Cardiol. 2018 Oct 30;72(18):2152-2163. (PMID: 30166084) J Vasc Surg. 2007 Jan;45 Suppl S:S5-67. (PMID: 17223489) Chest. 2010 Feb;137(2):263-72. (PMID: 19762550) Thromb Haemost. 2012 Jun;107(6):1172-9. (PMID: 22473219) BMC Cardiovasc Disord. 2017 Jan 4;17(1):1. (PMID: 28052754) J Am Heart Assoc. 2022 Jun 7;11(11):e025504. (PMID: 35621222) Clin Cardiol. 2020 May;43(5):524-531. (PMID: 32106334) Int J Mol Sci. 2022 Nov 29;23(23):. (PMID: 36499242) Stat Med. 2004 Jul 15;23(13):2109-23. (PMID: 15211606) PLoS One. 2016 Mar 17;11(3):e0151485. (PMID: 26986069) J Am Coll Cardiol. 2010 Mar 2;55(9):898-903. (PMID: 20185041) Sci Rep. 2022 Jul 29;12(1):12996. (PMID: 35906258) Acta Cardiol Sin. 2021 May;37(3):261-268. (PMID: 33976509) Atherosclerosis. 2012 Dec;225(2):517-20. (PMID: 23102450) Heart. 2013 Jun;99(12):843-8. (PMID: 23539553) J Am Coll Cardiol. 2018 May 22;71(20):2306-2315. (PMID: 29540326) J Geriatr Cardiol. 2013 Sep;10(3):258-66. (PMID: 24133514) Semin Intervent Radiol. 2014 Dec;31(4):378-88. (PMID: 25435665) Circ Cardiovasc Qual Outcomes. 2010 Nov;3(6):642-51. (PMID: 20940249) Eur J Vasc Endovasc Surg. 2012 Feb;43(2):198-207. (PMID: 22001145) Atherosclerosis. 2018 Aug;275:379-381. (PMID: 29843915) JAMA. 2021 Jun 01;325(21):2188-2198. (PMID: 34061140) Open Heart. 2021 Nov;8(2):. (PMID: 34815301) J Cheminform. 2014 Mar 29;6(1):10. (PMID: 24678909) J Adv Pract Oncol. 2016 Jan-Feb;7(1):91-100. (PMID: 27713848) J Child Psychol Psychiatry. 2010 Feb;51(2):152-61. (PMID: 19804382) Int Angiol. 2020 Dec;39(6):509-516. (PMID: 33140626) Am Heart J. 2018 May;199:83-91. (PMID: 29754671) J Formos Med Assoc. 2022 Aug;121(8):1363-1370. (PMID: 35410823) Psychol Bull. 2013 Nov;139(6):1342-96. (PMID: 23566018) Circ Res. 2019 Feb;124(3):416-425. (PMID: 30702997) |
فهرسة مساهمة: | Keywords: major adverse cardiovascular events (MACEs); major adverse limb events (MALEs); modified CHA2DS2-VASc risk (MCR) score; percutaneous transluminal angioplasty (PTA); peripheral artery disease (PAD) |
تواريخ الأحداث: | Date Created: 20240627 Latest Revision: 20240629 |
رمز التحديث: | 20240629 |
مُعرف محوري في PubMed: | PMC11202305 |
DOI: | 10.3390/biomedicines12061374 |
PMID: | 38927581 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2227-9059 |
---|---|
DOI: | 10.3390/biomedicines12061374 |